Company Search:
Advanced Search
Sponsored Links
Shanghai Pharmaceutical Company Limited Company Snapshot
Shanghai Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Pharmaceutical Company Limited with three other companies in this sector in China: China National Accord Medicines Corporation Limited (2015 sales of 25.99 billion Chinese Renmimbi [US$3.79 billion] of which 93% was Pharmaceutical Sales), Huadong Medicine Company Limited (21.73 billion Chinese Renmimbi [US$3.17 billion] of which 80% was Commerce), and Jointown Pharmaceutical Group Co Ltd (49.58 billion Chinese Renmimbi [US$7.23 billion] of which 97% was Distribution).

Sales Analysis. During the year ended December of 2015, sales at Shanghai Pharmaceutical Company Limited were 105.52 billion Chinese Renmimbi (US$15.39 billion). This is an increase of 14.2% versus 2014, when the company's sales were 92.40 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shanghai Pharmaceutical Company Limited (and since 2010, sales have increased a total of 182%). Sales of Retail Segment saw an increase that was more than double the company's growth rate: sales were up 43.7% in 2015, from 3.31 billion Chinese Renmimbi to 4.76 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Shanghai Pharmaceutical Company Limited
  Stock Performance Chart for Shanghai Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 20.33
(Figures in Chinese Renmimbi)
1 Week 1.7%   13 Weeks 6.2%  
4 Weeks 0.8%   52 Weeks 25.2%  
Shanghai Pharmaceutical Company Limited Key Data:
  Ticker: 601607 Country: China
  Exchanges: SHG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2015 Sales 105,516,587,000
(Year Ending Jan 2016).
Employees: 41,173
  Currency: Chinese Renmimbi Market Cap: 54,665,540,300
  Fiscal Yr Ends: December Shares Outstanding: 2,688,910,000
  Share Type: A Gu Closely Held Shares: 1,170,197,215
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.